Last 6 hoursStory cluster

GSK Partners with Sino to Boost Hepatitis B Drug in China

2 sources · 0 editorials3 factsMay 11 – May 11, 2026

Source coverage

Original publisher articles in this cluster. Broadside has not yet written editorial coverage.

GSK cuts deal with Sino to broaden reach of hepatitis B drug

via BioPharma Dive4 days ago

Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trial

via BioPharma Dive4 days ago

← Back to home